ReviewAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2025

Sotatercept: The First FDA-Approved Activin A Receptor IIA Inhibitor Used in the Management of Pulmonary Arterial Hypertension.

Josiah Villanueva et al.PubMed ↗Publisher ↗

No numbers read from the abstract.